Linked Life Data

7199253

Source:http://linkedlifedata.com/resource/pubmed/id/7199253

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1982-4-22
pubmed:abstractText
High-titer, low-avidity (HTLA) antibodies are frequently described as "reactive weakly by the antiglobulin test." These antibodies include: anti-Chido (Cha) and anti-Rodgers (Rga), and anti-Cost-Stirling (Csa) and anti-York (Yka), anti-Knops (Kna) and anti-McCoy (McCa), and anti-John Milton Hagen (JMH), the majority of which are directed at high-incidence red cell antigens. The classic HTLA antibodies are thought to be incapable of fixing complement or causing in vitro hemolysis. Present data indicate that these antibodies do not cause either increased red cell destruction when incompatible blood is transfused or hemolytic disease of the newborn. Special serological techniques can be used to differentiate the antibodies within the HTLA classification from antibodies not of an HTLA nature.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0002-9335
pubmed:author
pubmed:issnType
Print
pubmed:volume
47
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
789-95
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
1981
pubmed:articleTitle
Serological investigation and clinical significance of high-titer, low-avidity (HTLA) antibodies.
pubmed:publicationType
Journal Article